See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2016_Viridian_Therapeutics_Inc_DE.pdf
Logs
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 11,734,000 |
| 3 | PropertyPlantAndEquipment | 1,153,000 |
| 4 | remainder_Assets | 15,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 2,468,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 2,472,000 |
| 10 | GeneralAndAdministrativeExpense | 7,692,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 2,559,000 |
| 15 | ResearchAndDevelopmentExpense | 1,002,000 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 2,538,000 |
| 18 | remainder_NetIncome | 0 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,902,000 |
| 1 | Liabilities | 2,468,000 |
| 2 | Expenses | 13,725,000 |
| 3 | Revenues | 2,538,000 |
| 4 | StockholdersEquity | 10,434,000 |
| 5 | NetIncome | -11,187,000 |
| 6 | ComprehensiveNetIncome | -11,187,000 |
| 7 | BaseVar | 15,816,500 |
| 8 | EconomicCapitalRatio | 2.32 |
Edgar->Model Mapping
Feature Distribution
